ARTICLE | Company News
Ecole Polytechnique Federale de Lausanne, TES Pharma deal
August 17, 2015 7:00 AM UTC
TES and Ecole Polytechnique Federale de Lausanne (EPFL) partnered to develop small molecule modulators of the kynurenine pathway to treat metabolic disorders and age-related diseases. The companies c...